Radiant Biotherapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Radiant Biotherapeutics's estimated annual revenue is currently $5M per year.
- Radiant Biotherapeutics's estimated revenue per employee is $190,769
- Radiant Biotherapeutics's total funding is $43M.
Employee Data
- Radiant Biotherapeutics has 26 Employees.
- Radiant Biotherapeutics grew their employee count by 18% last year.
Radiant Biotherapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | Sr. Director - Discovery and Preclinical Development | Reveal Email/Phone |
4 | Research Scientist | Reveal Email/Phone |
5 | Associate Research Scientist | Reveal Email/Phone |
6 | Research Scientist | Reveal Email/Phone |
7 | Associate Research Scientist | Reveal Email/Phone |
8 | Associate Research Scientist | Reveal Email/Phone |
9 | Principal Scientist | Reveal Email/Phone |
10 | Associate Research Scientist | Reveal Email/Phone |
Radiant Biotherapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.2M | 27 | 29% | $5M | N/A |
#2 | $1.7M | 11 | 22% | N/A | N/A |
#3 | $0.9M | 11 | -72% | $39.4M | N/A |
#4 | $1M | 13 | -84% | $23.8M | N/A |
#5 | $94.4M | 609 | 8% | N/A | N/A |
#6 | $3.4M | 22 | 10% | N/A | N/A |
#7 | $9.5M | 61 | -68% | N/A | N/A |
#8 | $18.1M | 117 | 30% | N/A | N/A |
#9 | $21.7M | 140 | -6% | N/A | N/A |
#10 | $1M | 13 | -41% | N/A | N/A |
What Is Radiant Biotherapeutics?
Radiant’s Multabody™ platform enables multi-valent, multi-specific antibodies that have the potential to transform the treatment of cancer, inflammation, infections and other heterogeneous diseases. This breakthrough in antibody engineering combines avidity – superior binding power – with multi-specificity to create multifunctional biologics with the potential to unlock biology not achievable with current antibodies. Multabodies are a new class of biologics built on a modular, fully human scaffold, simplifying development while leveraging existing antibody manufacturing processes. We are rapidly advancing this superior next-generation therapeutic platform for a variety of indications. Learn more at radiantbio.com.\n \n\n \n \n Show more\n \n\n \n\n\n \n \n Show less
keywords:N/A
$43M
Total Funding
26
Number of Employees
$5M
Revenue (est)
18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Toronto
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.6M | 26 | -16% | N/A |
#2 | $4.5M | 26 | -13% | N/A |
#3 | $2.6M | 26 | N/A | N/A |
#4 | $1.9M | 26 | -24% | $305M |
#5 | $4.4M | 26 | 4% | N/A |